MELFLUFEN Trademark

Trademark Overview

On Monday, December 16, 2013, a trademark application was filed for MELFLUFEN with the United States Patent and Trademark Office. The USPTO has given the MELFLUFEN trademark a serial number of 79142011. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Saturday, December 16, 2023. This trademark is owned by Oncopeptides AB. The MELFLUFEN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical, medicinal and veterinary preparations for the treatment of cancer, neoplastic diseases and multiple myeloma
melflufen

General Information

Serial Number79142011
Word MarkMELFLUFEN
Filing DateMonday, December 16, 2013
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSaturday, December 16, 2023
Registration Number4792385
Registration DateTuesday, August 18, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 2, 2015

Trademark Statements

Goods and ServicesPharmaceutical, medicinal and veterinary preparations for the treatment of cancer, neoplastic diseases and multiple myeloma

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, March 4, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOncopeptides AB
Party Type30 - Original Registrant
Legal Entity Type09 - Joint Stock Company
AddressSE
Party NameOncopeptides AB
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressSE
Party NameOncopeptides AB
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressSE

Trademark Events

Event DateEvent Description
Tuesday, March 25, 2014NON-FINAL ACTION WRITTEN
Thursday, January 30, 2014SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, January 31, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 4, 2014APPLICATION FILING RECEIPT MAILED
Monday, March 24, 2014ASSIGNED TO EXAMINER
Wednesday, March 26, 2014NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, April 9, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 26, 2014REFUSAL PROCESSED BY MPU
Wednesday, March 26, 2014NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, April 11, 2014REFUSAL PROCESSED BY IB
Tuesday, October 28, 2014EXAMINERS AMENDMENT -WRITTEN
Tuesday, October 28, 2014EXAMINER'S AMENDMENT ENTERED
Wednesday, October 29, 2014EXAMINERS AMENDMENT MAILED
Friday, November 7, 2014NON-FINAL ACTION WRITTEN
Monday, November 10, 2014NON-FINAL ACTION MAILED
Tuesday, June 2, 2015PUBLISHED FOR OPPOSITION
Tuesday, April 14, 2015ASSIGNED TO LIE
Wednesday, April 15, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 15, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 22, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 27, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 13, 2015NOTICE OF PUBLICATION
Wednesday, May 13, 2015NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, May 13, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Monday, June 1, 2015NOTIFICATION PROCESSED BY IB
Thursday, September 21, 2017NEW REPRESENTATIVE AT IB RECEIVED
Friday, March 4, 2022CANCELLED SECTION 71
Wednesday, July 1, 2015NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, July 1, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, July 17, 2015NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, August 18, 2015REGISTERED-PRINCIPAL REGISTER
Wednesday, November 18, 2015FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, February 2, 2016FINAL DISPOSITION PROCESSED
Tuesday, February 2, 2016FINAL DISPOSITION NOTICE SENT TO IB
Saturday, February 20, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, November 30, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, November 4, 2022TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Wednesday, November 30, 2022INVALIDATION PROCESSED
Tuesday, December 27, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Saturday, November 4, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, July 9, 2024DEATH OF INTERNATIONAL REGISTRATION

Related Keywords

melflufen neoplastic diseases multiple myeloma cancer treatment medicinal veterinary preparations pharmaceutical